Clinical Trials Sponsored by Ferrer Laboratories

Total 4017 results

Forest Laboratories

Completed

Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) (VLZ-MD-22)

Major Depressive Disorder

United States, Canada
Forest Laboratories

Completed

A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-23)

Major Depressive Disorder

United States, Canada
Forest Laboratories

Terminated

Efficacy and Safety Study of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis

Proctitis, Ulcerative

United States, Poland, Canada
Prometheus Laboratories

Completed

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Metastatic Renal Cell Carcinoma | Metastatic Melanoma

United States
Prometheus Laboratories

Terminated

Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients

Crohn's Disease

United States
Forest Laboratories

Completed

Diafert® for Embryo Selection and Fertility Improvement (DESTINy)

Infertility

France
Forest Laboratories

Completed

Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage

Infertility

United States
Braintree Laboratories

Completed

A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris

Acne Vulgaris

United States
Forest Laboratories

Completed

Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance

Systemic Inflammatory Response Syndrome (SIRS) | Augmented Renal Clearance (ARC)

United States, Australia
Forest Laboratories

Terminated

Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg

Diarrhea-predominant Irritable Bowel Syndrome

France, Germany
Forest Laboratories

Completed

Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy

Helicobacter Infections

United Kingdom
Forest Laboratories

Completed

Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age

Infection

United States
Forest Laboratories

Completed

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia (CAP)

Bacterial Pneumonia

United States, Russian Federation, Bulgaria, Germany, Poland, Romania, Ukraine, Argentina, Austria, Brazil, Estonia, France, Georgia, Hungary, India, Lithuania, Malaysia, Serbia, Slovakia, South Africa, Spain, Switzerland, Thailand
Forest Laboratories

Completed

A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021

Eosinophilic Esophagitis

United States
Forest Laboratories

Completed

Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia

Gastroparesis

Australia
Forest Laboratories

Completed

Effects of Itopride on Gastric Motor and Sensory Functions in Healthy Volunteers

Healthy

United States
Forest Laboratories

Completed

Efficacy and Safety of Itopride vs Placebo in Heartburn

Heartburn

United States
Forest Laboratories

Completed

Effect of Azimilide Dihydrochloride on Renal Function

Healthy

United States
Forest Laboratories

Terminated

A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.

Coronary Artery Disease

United States
Forest Laboratories

Completed

A Study to Determine the Effect of Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With Chronic Anal Fissures

Pain | Fissure in Ano
Braintree Laboratories

Completed

A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing Colonoscopy

Bowel Preparation for Colonoscopy

United States
Forest Laboratories

Completed

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Bipolar 1 Disorder

United States, Bulgaria, Croatia, India, Philippines, Romania, Russian Federation, Serbia, Turkey, Ukraine
Forest Laboratories

Completed

Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)

Bipolar I Disorder

United States
Forest Laboratories

Completed

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Major Depressive Disorder

United States, Bulgaria, Finland, Germany, Romania, Russian Federation, Serbia, Ukraine
Forest Laboratories

Withdrawn

Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure

Anal Fissure

United States
Forest Laboratories

Terminated

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Autistic Disorder | Autism | Asperger's Disorder | Autism Spectrum Disorder (ASD) | Asperger's | Pediatric Autism | Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

United States, Estonia, Hungary, Iceland, Italy, Korea, Republic of, Serbia, Ukraine, Canada, Colombia, Belgium, France, New Zealand, Poland, South Africa, Spain
Forest Laboratories

Completed

Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo

Healthy

United States
Greer Laboratories

Completed

Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy

Allergy

United States
Greer Laboratories

Completed

Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies

Allergic Rhinitis

United States
Braintree Laboratories

Completed

BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

Endoscopy | Colonoscopy | Bowel Preparation

United States
Forest Laboratories

Completed

Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

Staphylococcus Aureus Bacteremia | Methicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia

United States
Braintree Laboratories

Completed

A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults

Constipation

United States
Forest Laboratories

Completed

Study of Blood Levels of Ceftaroline Fosamil in Children Who Are Receiving Antibiotic Therapy in the Hospital

Infections

United States
Forest Laboratories

Completed

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

Stage 2 Hypertension | Stage 1 Hypertension

United States
Forest Laboratories

Completed

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Exocrine Pancreatic Insufficiency: Cystic Fibrosis

United Kingdom, Italy, Belgium, Bulgaria, France, Germany, Poland
Forest Laboratories

Completed

A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)

Chronic Pancreatitis | Exocrine Pancreatic Insufficiency

United States, Italy, Ukraine
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder

Major Depressive Disorder

United States, Canada
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories

Completed

Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

Hypertension

United States
Forest Laboratories

Terminated

Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2) (SHIELD-2)

Heart Diseases | Cardiovascular Diseases | Arrhythmias, Cardiac | Implantable Cardioverter Defibrillator

United States, Belgium, Canada, Czech Republic, Denmark, France, Germany, Israel, Italy, Netherlands, Poland, Spain, Sweden
Braintree Laboratories

Completed

A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children

Constipation

United States
Braintree Laboratories

Completed

A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.

Colonoscopy

United States
Braintree Laboratories

Completed

Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation

Constipation

United States
Braintree Laboratories

Completed

An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients

Constipation

United States
Forest Laboratories

Unknown

Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment

Hypertension

United States
Forest Laboratories

Completed

Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis

Eosinophilic Esophagitis

United States
Braintree Laboratories

Completed

BLI801 Laxative in Constipated Adults

Constipation

United States
Forest Laboratories

Completed

The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories

Completed

Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)

Stroke, Acute

United States, Austria, Australia, Canada, Finland, Germany, Netherlands, Spain
Forest Laboratories

Completed

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Schizophrenia

United States

3

Subscribe